Charles C. N. Wang

ORCID: 0000-0002-7305-3061 · 1 paper in corpus · active 2019

Study types

  • article 1
article 2019
·doi:10.1038/s41598-019-48169-2

Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MD…